De novo cancer in patients on dialysis and after renal transplantation: north-western Italy, 1997–2012
Author:
Funder
Associazione Italiana per la Ricerca sul Cancro (IT)
Ministero della Salute
Ministero della Salute (IT)
Publisher
Springer Science and Business Media LLC
Subject
Nephrology
Link
http://link.springer.com/article/10.1007/s40620-017-0385-y/fulltext.html
Reference21 articles.
1. Buell JF, Gross TG, Woodle S (2005) Malignancy after transplantation. Transplantation 80:S254–S264
2. Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M (2004) Malignancy in renal transplantation. J Am Soc Nephrol 15:1582–1588
3. Piselli P, Busnach G, Fratino L et al (2013) De Novo malignancies after organ transplantation: focus on viral infections. Curr Mol Med 13:1217–1227
4. Ponticelli C, Cucchiari D, Bencini P (2014) Skin cancer in kidney transplant recipients. J Nephrol 27:385–394
5. Piselli P, Serraino D, Segoloni GP et al (2013) Risk of de novo cancer after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997–2009. Eur J Cancer 49:336–344
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy;Journal of Clinical Medicine;2023-10-21
2. How to Estimate the Probability of Tolerance Long-Term in Liver Transplant Recipients;Journal of Clinical Medicine;2023-10-16
3. Temporal trends of de novo urological malignancy in renal transplant recipients without a cancer history: A longitudinal cohort study;Clinical Transplantation;2023-06-12
4. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis;Open Life Sciences;2023-01-01
5. Durable effect of pyrotinib plus capecitabine in HER-2+ breast cancer patient undergoing peritoneal dialysis: A case report and literature review;Frontiers in Oncology;2022-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3